ALLR
ALLR
Last
$0.99
Day
-1.0%
1y
-44.2%
5y
-100.0%
52w
-46.6%
SPY YTD
+13.3%
Sec
—
Earnings
2026-11-1333d
EMA 21
1.08
EMA 50
1.18
EMA 200
145.28
20d high
-22.5%
5y high
-100.0%
5y range
0th
Positions held
Your positionsALLR isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-12
Hold
avoid
Signal
Sell
Target
$1.13
Stop
$0.86
Stop distance
13.1%
Target vs last
+14.1%
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-05 · New Valion Bio Board Chair Thomas Jensen Brings Biotech Turnaround Experience to the Advancement of Entolimod
2026-09-28 · Allarity Therapeutics Expands Laboratory Capabilities to Include Proteomics and Cell Line Research
2026-09-11 · Allarity Therapeutics Announces Strategic Capital Allocation for Filing of SPAC Registration Statement
2026-07-22 · Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?
Price (daily)
Full chart · RSI · MACD · patternsALLR · daily-16.1% over 14 sessions
Close EMA21 EMA50 EMA200